Phase IB trial of ACY-1215 (Ricolinostat) combined with nab-paclitaxel in metastatic breast cancer.

被引：0
|
作者：
Kalinsky, Kevin
Onishi, Maika
Yu, JiYang
Trivedi, Meghna S.
Accordino, Melissa Kate
Crew, Katherine D.
机构：
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2018年 / 36卷 / 15期
关键词：
D O I：
10.1200/JCO.2018.36.15_suppl.1058
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1058
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Phase Ib study of gemcitabine, nab-paclitaxel, and ficlatuzumab in patients with advanced pancreatic cancer
    Perez, Kimberly
    Weekes, Colin D.
    Cleary, James M.
    Abrams, Thomas Adam
    Blaszkowsky, Lawrence Scott
    Enzinger, Peter C.
    Giannakis, Marios
    Goyal, Lipika
    Meyerhardt, Jeffrey A.
    Rubinson, Douglas Adam
    Yurgelun, Matthew B.
    Stonely, Danielle
    Raghavan, Srivatsan
    Bakir, Basil
    Das, Koushik
    Pitarresi, Jason
    Aguirre, Andrew
    Needle, Michael N.
    Rustgi, Anil
    Wolpin, Brian M.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (04)
  • [42] Phase Ib/II study of ALT-803 in combination with gemcitabine and nab-paclitaxel in patients with advanced pancreatic cancer.
    Acoba, Jared David
    Rock, Amy
    Wong, Hing C.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (04)
  • [43] A Real-World Efficacy of Nab-Paclitaxel Monotherapy in Metastatic Breast Cancer
    Kim, Jung Sun
    Suh, Koung Jin
    Lee, Dae-Won
    Woo, Go-Un
    Kim, Miso
    Kim, Se Hyun
    Ryu, Han Suk
    Lee, Kyung-Hun
    Kim, Tae-Yong
    Han, Sae-Won
    Park, So Yeon
    Park, In Ae
    Kim, Jee Hyun
    Im, Seock-Ah
    CANCER RESEARCH AND TREATMENT, 2022, 54 (02): : 488 - 496
  • [44] Evaluating the role of nab-paclitaxel (Abraxane) in women with aggressive metastatic breast cancer
    Ciruelos, Eva
    Jackisch, Christian
    EXPERT REVIEW OF ANTICANCER THERAPY, 2014, 14 (05) : 511 - 521
  • [45] A randomized trial of pharmacological ascorbate, gemcitabine, and nab-paclitaxel for metastatic pancreatic cancer
    Bodeker, Kellie L.
    Smith, Brian J.
    Berg, Daniel J.
    Chandrasekharan, Chandrikha
    Sharif, Saima
    Fei, Naomi
    Vollstedt, Sandy
    Brown, Heather
    Chandler, Meghan
    Lorack, Amanda
    McMichael, Stacy
    Wulfekuhle, Jared
    Wagner, Brett A.
    Buettner, Garry R.
    Allen, Bryan G.
    Caster, Joseph M.
    Dion, Barbara
    Kamgar, Mandana
    Buatti, John M.
    Cullen, Joseph M.
    REDOX BIOLOGY, 2024, 77
  • [46] Final report: A phase I trial of BYL719 in combination with gemcitabine and nab-paclitaxel in locally advanced and metastatic pancreatic cancer.
    Soares, Heloisa P.
    Al-Toubah, Taymeyah E.
    Kim, Richard D.
    Kim, Jongphil
    Lewis, Neron K.
    Mahipal, Amit
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (04)
  • [47] A phase I trial with cohort expansion of BYL719 in combination with gemcitabine and nab-paclitaxel in locally advanced and metastatic pancreatic cancer.
    Soares, Heloisa P.
    Springett, Gregory M.
    Kim, Richard D.
    Williams-Elson, Irene
    Miller, Kara
    Kothari, Nishi
    Mahipal, Amit
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (04)
  • [48] nab-Paclitaxel in metastatic Breast Cancer High Effectiveness by tumor directed Effect
    不详
    BREAST CARE, 2015, 10 (04) : 291 - 291
  • [49] A cost-utility analysis of gemcitabine plus nab-paclitaxel in metastatic pancreatic cancer.
    Ko, Yoo-Joung
    Tam, Vincent Channing
    Mittmann, Nicole
    Pasteka, Mark
    Chan, Kelvin K.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [50] Phase II trial of weekly nab (nanoparticle albumin-bound)-paclitaxel (nab-paclitaxel) (Abraxane®) in combination with gemcitabine in patients with metastatic breast cancer (N0531)
    Roy, V.
    LaPlant, B. R.
    Gross, G. G.
    Bane, C. L.
    Palmieri, F. M.
    ANNALS OF ONCOLOGY, 2009, 20 (03) : 449 - 453
12345